Cargando…

Evaluation of metal‐conjugated compounds as inhibitors of 3CL protease of SARS‐CoV

3C‐like (3CL) protease is essential for the life cycle of severe acute respiratory syndrome‐coronavirus (SARS‐CoV) and therefore represents a key anti‐viral target. A compound library consisting of 960 commercially available drugs and biologically active substances was screened for inhibition of SAR...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hsu, John T.-A., Kuo, Chih-Jung, Hsieh, Hsing-Pang, Wang, Yeau-Ching, Huang, Kuo-Kuei, Lin, Coney P.-C., Huang, Ping-Fang, Chen, Xin, Liang, Po-Huang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2004
Materias:	Short Communications
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7134601/ https://www.ncbi.nlm.nih.gov/pubmed/15358550 http://dx.doi.org/10.1016/j.febslet.2004.08.015

Ejemplares similares

Structural basis of mercury‐ and zinc‐conjugated complexes as SARS‐CoV 3C‐like protease inhibitors
por: Lee, Cheng-Chung, et al.
Publicado: (2007)

Inhibition of SARS-CoV 3C-like Protease Activity by Theaflavin-3,3′-digallate (TF3)
por: Chen, Chia-Nan, et al.
Publicado: (2005)

Individual and common inhibitors of coronavirus and picornavirus main proteases
por: Kuo, Chih-Jung, et al.
Publicado: (2009)

Engineering a novel endopeptidase based on SARS 3CL(pro)
por: Kuo, Chih-Jung, et al.
Publicado: (2009)

Mechanism of the Maturation Process of SARS-CoV 3CL Protease
por: Hsu, Min-Feng, et al.
Publicado: (2005)

Inhibition of the severe acute respiratory syndrome 3CL protease by peptidomimetic α,β-unsaturated esters
por: Shie, Jiun-Jie, et al.
Publicado: (2005)

Characterization of SARS main protease and inhibitor assay using a fluorogenic substrate()
por: Kuo, Chih-Jung, et al.
Publicado: (2004)

In silico and in vitro analysis of small molecules and natural compounds targeting the 3CL protease of feline infectious peritonitis virus
por: Theerawatanasirikul, Sirin, et al.
Publicado: (2020)

Design, synthesis, and evaluation of trifluoromethyl ketones as inhibitors of SARS-CoV 3CL protease
por: Shao, Yi-Ming, et al.
Publicado: (2008)

Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors
por: Iketani, Sho, et al.
Publicado: (2020)

Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors
por: Iketani, Sho, et al.
Publicado: (2021)

Corrigendum to “Individual and common inhibitors of coronavirus and picornavirus main proteases” [FEBS Lett. 583 (2009) 549–555]
por: Kuo, Chih-Jung, et al.
Publicado: (2009)

Stable Benzotriazole Esters as Mechanism-Based Inactivators of the Severe Acute Respiratory Syndrome 3CL Protease
por: Wu, Chung-Yi, et al.
Publicado: (2006)

Binding interaction of SARS coronavirus 3CL(pro) protease with vacuolar‐H(+) ATPase G1 subunit
por: Lin, Cheng-Wen, et al.
Publicado: (2005)

Synthesis, docking studies, and evaluation of pyrimidines as inhibitors of SARS-CoV 3CL protease
por: Ramajayam, R., et al.
Publicado: (2010)

Author Correction: Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors
por: Iketani, Sho, et al.
Publicado: (2021)

Synthesis and evaluation of isatin derivatives as effective SARS coronavirus 3CL protease inhibitors
por: Chen, Li-Rung, et al.
Publicado: (2005)

Identification of non-covalent 3C-like protease inhibitors against severe acute respiratory syndrome coronavirus-2 via virtual screening of a Korean compound library
por: Lee, Joo-Youn, et al.
Publicado: (2021)

Kinetic Characterization and Inhibitor Screening for the Proteases Leading to Identification of Drugs against SARS-CoV-2
por: Kuo, Chih-Jung, et al.
Publicado: (2021)

Tribological Properties of Oil-in-Water Emulsion with Carbon Nanocapsule Additives
por: Jeng, Yeau-Ren, et al.
Publicado: (2020)

Screening of drugs by FRET analysis identifies inhibitors of SARS-CoV 3CL protease
por: Liu, Yu-Chih, et al.
Publicado: (2005)

Design, synthesis, and evaluation of 3C protease inhibitors as anti-enterovirus 71 agents
por: Kuo, Chih-Jung, et al.
Publicado: (2008)

Structural Basis of Inhibition Specificities of 3C and 3C-like Proteases by Zinc-coordinating and Peptidomimetic Compounds
por: Lee, Cheng-Chung, et al.
Publicado: (2009)

In silico screening of potential compounds from begonia genus as 3CL protease (3Cl pro) SARS-CoV-2 inhibitors
por: Maulana, Saipul, et al.
Publicado: (2023)

Associations and Interactions between Heavy Metals with White Blood Cell and Eosinophil Count
por: Huang, Chao-Hsin, et al.
Publicado: (2022)

Synthesis and evaluation of pyrazolone compounds as SARS-coronavirus 3C-like protease inhibitors
por: Ramajayam, R., et al.
Publicado: (2010)

Plant Products as Inhibitors of Coronavirus 3CL Protease
por: Mandal, Anirban, et al.
Publicado: (2021)

In silico approach for identification of natural compounds as potential COVID 19 main protease (M(pro)) inhibitors
por: Chaturvedi, Monika, et al.
Publicado: (2021)

Cloward’s approach for Pancoast neurogenic tumors: illustrative cases
por: Kuo, Yi-Hsuan, et al.
Publicado: (2021)

Surgical Approach May Influence Survival of Large-Diameter Head Metal-on-Metal Total Hip Arthroplasty: A 6- to 10-Year Follow-Up Study
por: Hu, Chih-Chien, et al.
Publicado: (2017)

Rescuing apoptotic neurons in Alzheimer’s disease using wheat germ agglutinin-conjugated and cardiolipin-conjugated liposomes with encapsulated nerve growth factor and curcumin
por: Kuo, Yung-Chih, et al.
Publicado: (2015)

Structural-based virtual screening and in vitro assays for small molecules inhibiting the feline coronavirus 3CL protease as a surrogate platform for coronaviruses
por: Theerawatanasirikul, Sirin, et al.
Publicado: (2020)

Characterization of trans‐ and cis‐cleavage activity of the SARS coronavirus 3CL(pro) protease: basis for the in vitro screening of anti‐SARS drugs
por: Lin, Cheng-Wen, et al.
Publicado: (2004)

An Integrated Computational and Experimental Approach to Identifying Inhibitors for SARS-CoV-2 3CL Protease
por: Zhai, Tianhua, et al.
Publicado: (2021)

The immunomodulatory effects of TNF-α inhibitors on human Th17 cells via RORγt histone acetylation
por: Lin, Yi-Ching, et al.
Publicado: (2016)

Hybrid Approach to Identifying Druglikeness Leading Compounds against COVID-19 3CL Protease
por: Aqeel, Imra, et al.
Publicado: (2022)

In-silico approaches for identification of compounds inhibiting SARS-CoV-2 3CL protease
por: Zeyaullah, Md., et al.
Publicado: (2023)

A simplified cell-based assay to identify coronavirus 3CL protease inhibitors
por: Resnick, Samuel J., et al.
Publicado: (2020)

Hypericin Inhibit Alpha-Coronavirus Replication by Targeting 3CL Protease
por: Zhang, Yue, et al.
Publicado: (2021)

Gender Difference in the Associations among Heavy Metals with Red Blood Cell Hemogram
por: Huang, Chao-Hsin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_f60uu7mr5pnlr3cgjijorl6ege